Search Results

AnaMar, a clinical-stage biotech company developing first-in-class anti-fibrotic 5-HT2B receptor antagonists, announces that the European Medicines Agency and the United States Food and Drug Administration have granted orphan drug designation to its lead clinical candidate, AM1476 for the treatment of systemic sclerosis.

AnaMar, a clinical-stage biotech company developing a first-in-class, peripheral 5-HT2B receptor antagonist, AM1476, as a pan anti-fibrotic medicine, announces positive results from its Phase I study, and the completion of Phase II enabling pre-clinical studies for its initial orphan indication in systemic sclerosis characterized by lung and skin fibrosis.

Medical robotics innovatorNoah Medical today announced the final results from its FRONTIER Study, the platform’s first-in-human clinical trial testing the “Tool-in-Lesion” accuracy of its Galaxy System™, are now available for review in the Official Journal of the Asian Pacific Society of Respirology.

Radon Medical Imaging, a leading medical imaging equipment maintenance and repair services company, announced it was selected as the Medical Imaging Asset Management firm for several Vandalia Health facilities.

Tri-Tech Forensics, Inc., a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical, a globally renowned provider of innovative medical devices and trauma care solutions including tourniquets, hemostatics, splints, pelvic binders, and intraosseous access systems.

GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.

Soligenix, Inc. announced today the formation of a Medical Advisory Board (MAB) to provide medical/clinical strategic guidance to the Company as it advances the clinical development of SGX945 (dusquetide) for the treatment of Behçet’s Disease.

Averto Medical Inc, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, announced the closing of an oversubscribed $30.5 million Series A financing.

AltruBio Inc. today announced that management will participate in the following May 2024 medical conferences.

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Tomographic Ultrasound, announced that Rama Gundlapalli has joined the company as Vice President of Engineering.